New Leaf Venture Partners
VC
2005
$580 M
New York City, New York, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
We are currently investing out of two vehicles – NLV-III for venture investments and NLV Growth-I for private and public growth-stage biopharmaceuticals investments – and actively managing our fully committed portfolios – NLV-I and NLV-II – to advance the possibilities of healthcare by building the most innovative businesses that develop clinically important and commercially attractive healthcare solutions.
NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in four Sprout funds and four New Leaf funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry.
We have invested over $2 billion in over 150 companies through the NLVP and Sprout funds. We have had 38 companies taken public with 18 billion dollar companies.
Industry
Region of investment
New Leaf Venture Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
New Leaf Ventures I, L.P.
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Technology
Life Sciences
HealthTech
|
Seed
Series A
|
North America
|
$5-10 m
|
$8 M
|
December 2005
|
|
New Leaf Ventures II, L.P.
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Technology
Life Sciences
HealthTech
|
Seed
Series A
|
North America
|
$5-10 m
|
$103 M
|
August 2007
|
